A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

Conditions: Obesity Interventions: Drug: BI 456906; Drug: BI 1820237; Drug: Placebo for BI 1820237; Drug: Placebo for BI 456906 Sponsors: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials